Sandu Pharmaceuticals Share Price | Sandu Pharmaceuticals Stock Screener
SANDUPHQ
Pharmaceuticals
Share Price BSE
₹41.59
▲
0.24 (0.58%)
As of July 3, 2026, the Sandu Pharmaceuticals share price (BSE: SANDUPHQ) is ₹41.59, up 0.58% from the previous close, with shares trading between ₹41.00 and ₹41.60, and a 52-week range of ₹30.52–₹51.50.
Analyse SANDUPHQ share price charts and track historical price performance.
Use the Sandu Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sandu Pharmaceuticals Market Cap
₹40.00 Cr.
SANDUPHQ P/E Ratio (TTM)
25.75
Sandu Pharmaceuticals P/B Ratio
1.20
EPS (TTM)
₹1.60
Dividend Yield
1.93%
Debt to Equity
-
SANDUPHQ 52 Week High
₹51.50
Sandu Pharmaceuticals 52 Week Low
₹30.52
Operating Margin
3.00%
Profit Margin
-
SANDUPHQ Revenue (TTM)
₹14.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹56.00
Total Equity
₹42.00
Sandu Pharmaceuticals Share Price Chart
Screen Sandu Pharmaceuticals share price with an interactive chart. Analyse SANDUPHQ price trends and volatility across different timeframes.
Sandu Pharmaceuticals Company Profile - Fundamental Screener
Screen Sandu Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANDUPHQ shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE751D01014
Sandu Pharmaceuticals Balance Sheet Screener
Screen SANDUPHQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Assets | |||
| Total Assets | 56 | 52 | 54 |
| Current Assets | 26 | 22 | 26 |
| Fixed Assets | 18 | 18 | 17 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 42 | 41 | 39 |
| Share Capital | 10 | 10 | 10 |
| Reserves & Surplus | 32 | 31 | 30 |
Sandu Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen Sandu Pharmaceuticals income statement and profit fundamentals.
Analyze SANDUPHQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sandu Pharmaceuticals share price evaluation.
| Item | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar | 2021-Sept | 2021-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 18 | 18 | 17 | 16 | 18 | 17 | 18 | 15 | 17 | 17 | 16 | 12 | 18 | 17 |
| Expenses | 14 | 17 | 17 | 17 | 15 | 17 | 16 | 17 | 15 | 16 | 16 | 16 | 11 | 17 | 17 |
| EBITDA | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Operating Profit % | 3.00% | 5.00% | 5.00% | 2.00% | 4.00% | 3.00% | 5.00% | 2.00% | 3.00% | 5.00% | 5.00% | 2.00% | 5.00% | 5.00% | 4.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| EPS | 0.34 | 0.57 | 1.95 | 0.17 | 0.62 | 0.21 | 0.57 | 0.11 | 0.26 | 0.51 | 0.64 | 0.19 | 0.34 | 0.57 | 0.53 |
Sandu Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen SANDUPHQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 1 | 1 | 0 |
| Investing Activities | 0 | -1 | 1 |
| Financing Activities | -1 | -1 | 1 |
| Net Cash Flow | 0 | -1 | 1 |
Sandu Pharmaceuticals Shareholding Pattern Screener
See Sandu Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check Sandu Pharmaceuticals promoter holding and ownership changes for SANDUPHQ on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 37.79% | 37.79% | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% | 42.90% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.98% | 37.01% | 36.77% | 36.57% | 35.90% | 35.34% | 34.97% | 44.25% |
| Other Holding | 25.23% | 25.19% | 20.32% | 20.53% | 21.20% | 21.75% | 22.12% | 12.84% |
| Shareholder Count | 10,298 | 10,284 | 10,284 | 10,226 | 10,287 | 10,333 | 10,246 | 10,012 |
Sandu Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check Sandu Pharmaceuticals dividend history with payout and yield data.
View Sandu Pharmaceuticals dividend details including ex-dates and amounts for SANDUPHQ stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.80 | 2.62% |
| 2024-March | ₹0.80 | 1.63% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.75 | 1.43% |
| 2021-March | ₹0.50 | 0.71% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sandu Pharmaceuticals Stock Index Membership
See which indices include Sandu Pharmaceuticals stock.
Check SANDUPHQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sandu Pharmaceuticals Market Events Screener - Corporate Actions
Get Sandu Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check Sandu Pharmaceuticals stock events that may affect SANDUPHQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.80 /share | -12.97% | ||
| Dividend | ₹ 0.75 /share | 5.08% | ||
| Dividend | ₹ 0.75 /share | 41.02% | ||
| Dividend | ₹ 0.80 /share | 4.55% | ||
| Annual General Meeting | NA | 3.42% | ||
| Dividend | ₹ 0.50 /share | 0.87% | ||
| Annual General Meeting | NA | -3.84% | ||
| 2026-05-05 | 2026-05-05 | Quarterly Result Announcement | NA | -1.85% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 2.05% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.51% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 0.76% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 4.41% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -3.54% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 2.33% |
Sandu Pharmaceuticals Competitors Screener - Peer Comparison
Screen SANDUPHQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 453,978 | 38.82 | 58,220 | 6.38% | 11,565 | 62.37 |
| Divis Laboratories | 177,267 | 69.38 | 10,560 | 8.73% | 2,520 | 52.31 |
| Torrent Pharmaceuticals | 156,321 | 71.51 | 13,886 | 20.34% | 2,138 | 56.90 |
| Cipla | 119,156 | 30.13 | 29,045 | 2.24% | 3,870 | 65.46 |
| Dr Reddys Laboratories | 117,860 | 27.10 | 33,593 | -0.44% | 3,998 | 69.37 |
| Zydus Life Science | 112,517 | 21.63 | 26,720 | 13.65% | 5,242 | 61.62 |
| Lupin | 109,297 | 20.00 | 27,488 | 19.98% | 5,345 | 58.20 |
| Mankind Pharma | 103,337 | 52.44 | 14,278 | 12.03% | 1,750 | 57.08 |
| Aurobindo Pharma | 91,970 | 25.78 | 33,385 | 3.21% | 3,376 | 67.06 |
| Laurus Labs | 79,829 | 88.02 | 6,868 | 22.01% | 890 | 64.65 |
Sandu Pharmaceuticals Company Announcements - News Screener
Screen SANDUPHQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-02 | Closure of Trading Window | - |
| 2026-06-27 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-06-27 | Announcement under Regulation 30 (LODR)-Cessation | - |
| 2026-06-27 | Announcement under Regulation 30 (LODR)-Demise | - |
| 2026-06-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-18 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-07 | Announcement Under Regulation 30-Update Demand Order From Office Of Assistant Commissioner Jurisdiction Sector 3 (Mobile Squad-1) Shamli State/UT Uttar Pradesh For Detention Of Conveyance & Goods Due To Discrepancy In Quantity As Per Invoice & Quantity As | - |
| 2026-05-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-05 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-05-05 | Statement Of Deviation And Variation Of Funds For Q Ended 31.03.2026 | - |
| 2026-05-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-05 | Corporate Action-Board approves Dividend | - |
| 2026-05-05 | Audited Financials For The Q And Year Ended 31.03.2026 | - |
| 2026-05-05 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 05Th May 2026 | - |
| 2026-04-27 | Corporate Action-Board to consider Dividend | - |
| 2026-04-27 | Board Meeting Intimation for 1.Approval Of The Audited Financial Results For The Q And Year Ended 31.03.2026 2.To Recommend Final Dividend If Any. | - |
| 2026-04-20 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-21 | Closure of Trading Window | - |